Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Provexis PLC - Reading, England-based producer of heart-health functional food ingredient Fruitflow - Enters transfer of business deal and a premix and market-ready solutions supply deal for its product Fruitflow. Both will take effect from January 1, 2023. Says the agreements should lead to a substantial increase annual sales and net profit.
Expects to report revenue of £426,000 for the year ended March 31 and an underlying operating loss of £173,000. Revenue for financial 2021 amounted to £211,195.
Files new patent application related to the use of Fruitflow to confer health benefits in modulating the gut microbiome of humans.
Fruitflow is a supplement that supports healthy blood flow and heart health, Provexis explains.
Current stock price: 0.98 pence, up 13% on Wednesday
12-month change: down 17%
Copyright 2021 Alliance News Limited. All Rights Reserved.